Lithium and coronaviral infections. A scoping review. [version 2; peer review: 3 approved]
description: The current rapid spread of the novel coronavirus (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) calls for a rapid response from the research community. Lithium is widely used to treat bipolar disorder, but has been shown to exhibit antiviral activity. This brief review took a systematic approach to identify six in vitro studies reporting on the influence of lithium on coronaviral infections. We propose mechanistic investigation of the influence of lithium – alone and with chloroquine – on the SARS-CoV-2 infection.
creator: Jarosław Walkowiak, Jan K Nowak
source: F1000Research
publisher: F1000 Research Ltd
date: 2020
identifier: DOI: 10.12688/f1000research.22299.2
coverage: Biology (General), Medicine